PGY2 Oncology Pharmacy Residency Manual
DEPARTMENT OF PHARMACY SERVICESPGY2 Oncology PharmacyResidency ManualPGY2 Oncology Residency ProgramUniversity Medical Center, University of Louisville HospitalLouisville, KYRevised: November 2016
University Medical Center, University of Louisville Hospital2PGY2 ONCOLOGY PHARMACY RESIDENCY MANUAL & TRAINING AGREEMENTTABLE OF CONTENTS Department of Pharmacy Mission and Vision Statement (Page 3) Departmental Organization Chart (Page 4) Hospital Fundamentals of Communication –AIDET (Pages 4-5) Pharmacy Residency Program Descriptions (Pages 5-7) PGY2 Oncology Program Structure (Pages 8-16) PGY2 Program Completion Requirements (Page 16) Facilitators of the Residency Program (Pages 16-20) Orientation (Pages 20-21) Resident Salary, Benefits, and Procedures (Pages 21-24) PGY2 Oncology Program Responsibilities (Pages 24-29) Resident Personal Responsibilities (Pages 29-30) Residency Policies (Pages 30-37) Resident Policy and Training Agreement (page 37)Page 2 of 39
University Medical Center, University of Louisville Hospital3PGY2 ONCOLOGY PHARMACY RESIDENCY MANUAL & TRAINING AGREEMENTINSERT LOGO HEREMISSION STATEMENTThe fundamental goal of the PGY2 Oncology Pharmacy Residency program is to:Create pharmacists with the ability to function independently as oncology pharmacy specialistsin practice settings including adult hospital oncology services, ambulatory care oncology andclinical faculty appointments.The residents will be encouraged to develop an approach to their profession that leads to life-longlearning and career satisfaction. Pharmacists who successfully complete the PGY2 OncologyPharmacy Residency program at University of Louisville Hospital will be proficient in providingintegrated pharmaceutical care to oncology patients as competent practitioners in multiplehealthcare environments. This program will provide residents with the learning experiences andopportunities that will guide them to enhance their ability to design, implement and improveclinical oncology pharmacy services. Residents will apply their expertise in our tertiary teachinghospital setting, oncology pharmacy, and ambulatory clinics. This will provide experience incaring for a variety of patients across the continuum.DEPARTMENT OF PHARMACYMISSION AND VISION STATEMENTMISSION:To optimize patient outcomes by providing progressive pharmacy services as part of aninterdisciplinary healthcare team and advance the pharmacy profession through education,research, and the development of future healthcare professionals.VISION:To provide unparalleled pharmacy services in a matter that fosters continued learning,interdisciplinary collaboration, and patient-centered care.Page 3 of 39
University Medical Center, University of Louisville Hospital4PGY2 ONCOLOGY PHARMACY RESIDENCY MANUAL & TRAINING AGREEMENTDEPARTMENTAL ORGANIZATIONINSERT ORGCHARTHEREPage 4 of 39
University Medical Center, University of Louisville Hospital5PGY2 ONCOLOGY PHARMACY RESIDENCY MANUAL & TRAINING AGREEMENTHOSPITAL FUNDAMENTALSOF COMMUNICATION—AIDETAIDET: Five Fundamentals of Patient Communication provides a template for a very goodexchange of information in every patient or family encounter. Patients hospitalized for theaverage length of stay of 3.5 days encounter about 74 different staff members. Only about 42percent of the staff introduces themselves! That means that the average patient sees about 40people who have not taken the first step in service excellence.What is AIDET: Five Fundamentals of Patient lanationThank You1. A - Acknowledge:Whether you acknowledge patients by name or with a friendly smile, patients know thatyou have connected with them. Acknowledgment includes putting down paperwork andmaking the patient your focus. Eye contact, a pat on the shoulder, and a smile are all nonverbal ways of acknowledging a patient or family member.2. I - Introduce:Introduce yourself by name, state your department, and describe what you are going to do."Good morning, Mr. Jones. My name is Mary, and I am here to start your IV. I am part ofthe special IV team at the hospital, and I will do everything to make this as comfortable aspossible for you."3. D - Duration:Give an estimate of the time it will take to complete the procedure. "It should take meonly about 15 minutes to register you." "The chest X-ray should take only about 10minutes. However, I would ask that you stay here in the room so I can run the filmthrough processing and make sure that I got a good, clear picture. That should add aboutanother 20 minutes and then you should be able to go. We will have the results to yourphysician's office by three this afternoon."4. E - Explanation:Explain what you are going to do to or for the patient. Ask if the patient has ever had thisX-ray done before or lab work drawn before. Ask if the patient has any concerns orquestions before you start or any information that may make the testing easier. Explain,explain, explain-all along the way. As the technologist, you may do this procedure manytimes a day. For the patient it may be the only time he or she has ever experienced it. If itis going to hurt, let the patient know. We also can integrate patient safety into thediscussion. For example, before drawing blood, the phlebotomist can say, "For yoursafety, I am going to check the test label against your ID wrist band."Page 5 of 39
University Medical Center, University of Louisville Hospital6PGY2 ONCOLOGY PHARMACY RESIDENCY MANUAL & TRAINING AGREEMENT5. T-Thank You:Thank the patient for choosing your hospital to have the test or treatment done. If thepatient is an inpatient ask, "Is there anything else I can do for you?" or, "Do you have anyquestions I can answer?"If every employee, in every patient and family encounter, utilized AIDET: Five Fundamentals ofPatient Communication, think about the impact this one hospital-wide initiative could have onimproving patient satisfaction. From questions reflecting all staff courtesy, keeping familyinformed, employees working together as a team, involving the patient in decisions about care,explaining tests and treatments, etc., this is an initiative that works everywhere. Everydepartment can work within these guidelines to create the five fundamentals of choice for eachdepartment.PHARMACY RESIDENCY PROGRAMSPOLICY 712-1600PURPOSE:To establish criteria for the training and education of residents in the fundamentals ofexemplary contemporary pharmacy practice.POLICY STATEMENT:A pharmacy residency is an organized, directed, postgraduate training program thatcenters on development of the knowledge, attitudes, and skills needed to pursue rationaldrug therapy.GUIDELINES:A. PGY-1 Program Director: The Chief Pharmacy Officer appoints a clinical pharmacist whohas a Doctor of Pharmacy to serve as the PGY-1 residency program director. The residencyprogram director must have demonstrated a sustained contribution and commitment topharmacy practice in addition to meeting the requirements set out by the residencyaccrediting body.B. PGY-2 Program Director: The Chief Pharmacy Officer appoints a clinical pharmacist whohas a Doctor of Pharmacy and expertise or training in a specialty area to serve as a PGY-2residency program director. The residency program director must have demonstrated asustained contribution and commitment to pharmacy practice in addition to meeting therequirements set out by the residency accrediting body.C. Preceptors: The residency program directors shall have authority to delegate preceptorialresponsibilities for specific segments of their respective residency programs to otherpharmacy practitioners. In addition to meeting the requirements set out by the residencyPage 6 of 39
University Medical Center, University of Louisville Hospital7PGY2 ONCOLOGY PHARMACY RESIDENCY MANUAL & TRAINING AGREEMENTaccrediting body, preceptors must have demonstrated a sustained contribution andcommitment to the respective area of pharmacy practice.D. Duties: Both the program director and preceptors have specific responsibilities to thepharmacy residents. These duties shall include:1. To provide residents with a residency specific orientation to University Hospital, thepharmacy department, and the Residency Learning System (RLS).2. To develop a plan and training schedule, in cooperation with resident, to achieve thepredetermined goals and objectives for the residency program. The plan shall beevaluated regularly and modified accordingly.3. To develop rotation specific goals and objectives and present them to the resident at thebeginning of each rotation.4. To provide an optimal learning experience for the residents.5. To promote continuous feedback and communication among the preceptors and residents.6. To provide training to the residents that creates competence in the following areas:PGY-1 Pharmacy ResidencyCritical CareInfectious DiseasePharmacy AdministrationOncologyDrug InformationInternal MedicineAmbulatory CareResearchPharmacy DistributionInformaticsTeachingSpecial Populations (BMT, Neuro ICU, Emergency Medicine, Neonatology)PGY-2 Oncology ResidencyMedical Oncology Gynecological OncologyBone Marrow Transplant Ambulatory CareAnti-neoplastic DistributionAdministrationPGY-2 Critical Care ResidencyEmergency MedicineMedical ICUEducation/TrainingPalliative CareResearchMultimodalityDrug informationNeurosurgical ICUInformaticsStrokePGY-2 Ambulatory Care ResidencyInternal MedicineUrgent Care/First CareOutpatient OncologyHIV/AIDSDiabetesTeachingMedication Therapy ManagementSurgical Y-2 Internal Medicine ResidencyInternal Med 1 & 2CardiologyInfectious DiseasesMedical ICUTeaching/EducationResearchDrug Policy/AdministrationGeriatrics Workforce Educational ProgramPage 7 of 39
University Medical Center, University of Louisville Hospital8PGY2 ONCOLOGY PHARMACY RESIDENCY MANUAL & TRAINING AGREEMENT7. To assure the residency program is aligned with and conforms to the standards set byASHP in order to maintain accreditation.8. To provide the resident, upon successful completion of the program, a certificate ofcompletion.REVISED: 05/99; 06/05; 09/09; 2/13Page 8 of 39
University Medical Center, University of Louisville Hospital9PGY2 ONCOLOGY PHARMACY RESIDENCY MANUAL & TRAINING AGREEMENTPGY2 ONCOLOGY PHARMACY RESIDENCYDETAILSSummary of Rotations and RequirementsCore Rotations: Orientation (one month)o Orientation to the hospital, pharmacy, drug distribution systems, computer systems,unit dose and IV admixture programs. The resident will receive a generalintroduction to the hospital which will include an orientation by the official hospitalhuman resources department, pharmacy department/residency program, mentorshipprogram, research program and hospital systems training by pharmacy informatics.The resident will then spend concentrated training in the inpatient IV room,inpatient hospital distribution area, IV chemotherapy compounding room andoncology pharmacy distribution role in the oncology pharmacy satellite. Inpatient Medical Oncology (two months)o The resident is expected to provide clinical pharmacy services to allmedical/oncology (MO) patients. The resident will participate in daily patientcare rounds with the MO Service. The oncology pharmacy resident is responsiblefor identifying and resolving any medication-related issues for all patients on theservice. The MO team consists of an oncology attending physician, 1-2 oncologyfellows, medical residents, a pharmacist, PGY2 oncology pharmacy resident, /PGY1 pharmacy resident, medical/pharmacy students. The MO service primarilyservices the solid tumor patient population; however, patients with hematologicaldisorders are also treated. Malignancy types most commonly cared for by theMO service include head and neck, pancreatic, breast, colorectal, lung, renal cell,and melanoma cancers. Daily patient care rounds are a required component ofthis rotation experience and residents are required to round 6 days a week.Expectations of the resident will increase from the first to the second month ofrotation. The first month of MO is expected to be completed near the beginning ofthe residency year and the second month is required to be completed in the secondhalf of the residency year. Inpatient Bone Marrow Transplant (two months)o The resident is expected to provide clinical pharmacy services to all patients onthe bone marrow transplant (BMT) service, which is comprised primarily ofpatients with leukemia, lymphoma, multiple myeloma, and other hematologicalmalignancies. The resident will participate in daily patient care rounds with thePage 9 of 39
University Medical Center, University of Louisville Hospital10PGY2 ONCOLOGY PHARMACY RESIDENCY MANUAL & TRAINING AGREEMENTBMT Service. The BMT team normally consists of an attending physician,oncology fellow, nurse practitioner, nurse clinician, and pharmacist. There mayalso be a PGY1 pharmacy resident and/or pharmacy student. The BMT pharmacyresident is responsible for identifying and resolving any medication-related issuesfor all patients on the service. Expectations of the resident will increase from thefirst to the second month of rotation. The rotation experience is set up as a twomonth sequential block. Daily patient care rounds are a required component ofthis rotation experience. The resident is expected to participate in patient roundswith the fellow, nurse practitioner or attending physician each morning prior toworking rounds. Residents are expected to round 6 days a week. Inpatient Gynecology/Oncology (one month)o The resident is expected to provide clinical pharmacy services to all patients onthis service. The resident will participate in daily patient care rounds with theGynOnc Service. The GynOnc team consists of an oncology attending physician,4 gynecological residents, medical students, a pharmacist, and a pharmacyresident. The GynOnc service is primarily comprised of patients with variousgynecological malignancies including, but not limited to, ovarian cancer, cervicalcancer, and endometrial cancer. The oncology pharmacy resident is responsiblefor identifying and resolving any medication-related issues for these patients.Daily patient care rounds are a required component of this rotation experience.The resident is expected to check with the GynOnc resident(s) to determine thetime of daily rounds for the following day. Residents are expected to round 6days a week. The resident may be scheduled for GynOnc at any month throughoutthe year. Ambulatory Care (two months)o Ambulatory care rotation is a two-month required learning experience for thePGY-2 oncology pharmacy resident. The practice area is located in the acrossvarious supportive care, solid and hematologic malignancy clinics located on the2nd and 3rd floor of Brown Cancer Center. The resident in clinic works incollaboration with the physicians, nurse clinicians, disease coordinators, andresearch coordinators in dosing, therapy choices, supportive care measures, oralchemotherapy, and acting as an educator/liaison between infusion nursing,pharmacy, and the medical oncology team both on a patient case-by-case basisand when new standards of care for specific diseases or medications emerge. Thepharmacy resident, under coaching and facilitation of the preceptor, will learn therole of a specialty pharmacist and provide care for outpatient oncology patients.The resident attends clinic four days per week. This rotation is scheduled in thelatter six months of the residency year.Longitudinal Rotations: (Throughout the year) Ambulatory Careo Longitudinal ambulatory care rotation is a ten-month required learning experiencefor the PGY-2 oncology pharmacy resident. The practice area is located in thePage 10 of 39
University Medical Center, University of Louisville Hospital11PGY2 ONCOLOGY PHARMACY RESIDENCY MANUAL & TRAINING AGREEMENTbreast clinic for approximately six month and the other six months is split equallybetween lung clinic and gastrointestinal malignancy clinic. These clinics arelocated on the 2nd and 3rd floor of Brown Cancer Center. The specialty pharmacistin these clinics works in collaboration with the physicians, nurse clinicians,disease coordinators, and research coordinators. The pharmacist provides clinicalsupport in decision making for drug dosing, therapy choices, supportive caremeasures, oral antineoplastic medications, and acts as an educator/liaison betweeninfusion nursing, pharmacy, and the medical oncology team both on a patientcase-by-case basis and when new standards of care for specific diseases ormedications emerge. The pharmacy resident, under coaching and facilitation ofthe preceptor, will learn the role of a specialty pharmacist and provide care foroutpatient oncology patients. The resident attends breast clinic one day of weekfor 4 months, gastrointestinal clinic and lung clinic each for 3 months throughoutthe residency year. Serviceo Distributive: Resident(s) will learn to effectively staff the oncology satelliteoutpatient pharmacy. Responsibilities include preparing and dispensing oncologydrugs and ancillary supportive medications according to facility requirements.The resident pharmacist will work in collaboration with the pharmacy technicians,nurses, physicians, and research coordinators in reviewing labs, documentingchemotherapy dispensed, preparing chemotherapy, and supervising thetechnicians. Additional duties will include providing drug information, assistingwith managing adverse drug reactions in the infusion clinic, checking orders foraccuracy, and other duties as the opportunity arises. Additionally, the residentwill provide clinical documentation of pharmacy services and providedecentralized order entry (while on inpatient rounding rotations) to ensure safeand appropriate medication therapy for patients. The resident is expected to worka total of 26, 8-hour distributive shifts in the oncology pharmacy satellitethroughout the residency year.o Administrative: Continuous participation in staff planning activities, learnprocess of developing oncology pharmacy budget, exposure to variousmanagement strategies, develop skills to create a new service within theorganization, develop leadership skills and participate in other opportunities thatrequire resident to interact with various departmental administrative teams. Researcho Resident(s) will complete a yearlong residency research project, submit the projectproposal to the project primary preceptor and residency director, obtain approvalfrom the hospital Institutional Review Board (IRB), participate in MicrosoftAccess training (if needed), prepare a poster for presentation at ASHP MCM orHOPA, prepare a final manuscript and submit manuscript for publication prior toresidency completion. The resident will be allotted 10 project days which canbe used for research and drug information projects. These days will take placethroughout the year with the majority occurring during orientation, core monthrotations, and the month of December. Additionally, the resident will work withPage 11 of 39
University Medical Center, University of Louisville Hospital12PGY2 ONCOLOGY PHARMACY RESIDENCY MANUAL & TRAINING AGREEMENTPharmacy Investigational Drug Services and be involved with a newly starting orongoing research protocol, including but not limited to, creating the study binder,attending site visits from the sponsor, attending the CSRC (clinical scienceresearch committee) for study review and creating the study prescriber ordertemplate. Throughout the residency year, the resident will continue to worklongitudinally toward accomplishing their research goals. Drug Informationo Resident(s) will complete a quality improvement or medication use evaluationproject. This project and its details will be presented to leadership uponcompletion typically during the second half of the year. If applicable theresident(s) will submit this project for
The residents will be encouraged to develop an approach to their profession that leads to life-long learning and career satisfaction. Pharmacists who successfully complete the PGY2 Oncology Pharmacy Residency program at University
RESIDENCY (PEDIATRIC) Program Overview This residency program is a PGY2 residency in Infectious Diseases in a pediatric hospital. The program is conducted from July 1, 2016 to June 30, 2017. Over this year the PGY2 ID resident will be actively involved in clinical, research, and academic activities pertaining to antimicrobial
Amanda N. Seddon, PharmD, BCPS, BCOP Director, PGY2 Oncology Pharmacy Residency . Myers RA, Wirth S, Williams S, Kiel PJ. Enasidenib: An Oral IDH2 Inhibitor for the . Fini M, Yan CH, Touchette DR, Stranges PM. Cost-effectiveness of office-based
PGY2 Ambulatory Care Pharmacy Residency University of Virginia Health System P.O. Box 800674 . and health care providers for health improvement and disease prevention, successful residents will be empowered to . Family Medicine Clinic ( 10 weeks) Cardiology ( 5 weeks)
6 — Oncology Nursing Society Oncology Nurse Navigator Core Competencies Overview Key Terms Used in This Document Oncology nurse navigator: An oncology nurse navigator (ONN) is a professional registered nurse with oncology-specific clinical knowledge who offers individualized assistance to patients, families, and caregivers to help overcome healthcare
Dr. TJ Emmons received his Doctor of Pharmacy degree from Samford University's McWhorter School of Pharmacy. He completed a PGY1 residency at the Lexington VA Healthcare System. After completing residency, he worked with Humana Pharmacy Solutions in their clinical pharmacy review department performing formulary management functions. Dr.
oncology pharmacists in an effort to unify practice. History of the Hematology/Oncology Pharmacy Association HOPA, a professional society for hematology/oncology pharmacists and associates, was launched in 2004. The goal of HOPA is to have an oncology pharmacist as an integral member of the care team for all individuals affected by can-cer.
Oncology pharmacy specialist -Oncology Pharmacist A licensed pharmacist with special training in how to design, give, monitor, and change chemotherapy for cancer patients. Also called BCOP and board certified oncology pharmacy specialist. Oncology pharmacists play an important role in the delivery of care for individuals living with cancer.
2 For referenced ASTM standards, visit the ASTM website, www.astm.org, or contact ASTM Customer Service at service@astm.org. For Annual Book of ASTM Standards volume information, refer to the standard’s Document Summary page on the ASTM website. 1
